Table 1.
Demographics | |
Age (yrs.) | 55 ±9 |
Race (no.(%)) | |
African American | 16(43) |
European American | 19(51) |
Other | 2(6) |
Comorbidities | 2.1 ± 1.9 |
BMI (kg/m2) | 31.8 ± 7.8 |
Waist circumference (cm) | 92 ± 16 |
Body fat (%)† | 46 ± 7 |
Cancer status | |
Months since diagnosis | 53 ± 60 |
Breast cancer stage (no.(%)) | |
DCIS | 5 (14) |
I | 11 (29) |
II | 17(46) |
III | 4(11) |
Chemotherapy (yes) | 26(70) |
Radiation (yes) | 20(54) |
Fitness and heart rate responses | |
Peak V02 (mL02 kg"1min1) | 20 ±5 |
%HRmax stage 1 | 61 ± 7 |
%HRmax stage 2 | 64 ± 8 |
%HRmax stage 3 | 70 ± 10 |
%HRmax stage 4 | 75 ± 11 |
Physical activity measures | |
TEE (kcal day_1)† | 2012 ±302 |
AEE (kcal day_1)† | 650 ± 229 |
MVPA (min week1) | 173 ± 90 |
Diet‡ | |
Sugar (g) | 85 ± 42 |
Carbohydrates (g) | 206 ± 66 |
Fiber (g) | 16 ± 8 |
Alpha diversity (au) | |
Chaol | 341 ± 44 |
Observed species | 277± 50 |
PD whole tree | 23± 4 |
Shannon | 5± 1 |
Simpson | 0.9± 0.08 |
n = 32;
n = 36;
BMI, body mass index; ductual incarcinoman in situ; Peak oxygen uptake (VO2) estimated from the graded exercise test; % HRmax stage 1–4, percent of age-predicted heart rate (HR) max derived(from 220-age)during stage 1–4 of modified-Naughton protocol; TEE, total energy expenditure; AEE, activity-related energy expenditure; MVPA,moderate-to-vigrorous physical activity. Diet represents daily averages. Values are shown as means and SD’s unless noted otherwise.